Novo Nordisk Finds Compounded Wegovy up to 33% Impure, Sues Florida Pharmacies

December 19, 2023
Lady justice and her scale

Novo Nordisk said it sued one compounding pharmacy and refiled a lawsuit against another after finding their products claiming to contain the active ingredient for its in-demand weight-loss drug Wegovy were impure, some by as much as 33%.

The Danish drugmaker said it found impurities in all the drugs tested from Wells Pharmacy and Brooksville Pharmaceuticals, both based in Florida. Novo first sued Brooksville in July, and discovered a substance called BPC-157 in samples from Wells.

Read more at Reuters >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • BTL Establishes New Laser Division and Introduces Exolase One
    • SkinMedica Launches Barrier Calming Cream
    • CEDR HR Solutions Supports AmSpa Members as Platinum Vendor Affiliate
    • Galderma Opens New U.S. and Latin America Headquarters in Miami
    • Raging Agency Becomes Silver Vendor Affiliate with the American Med Spa Association